MedTrace Logo

Standard and Immunostimulating Enteral Nutrition in Surgical Patients

NCT00576940 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2007-12-19

No results posted yet for this study

Summary

The aim of the study was to assess the clinical effect of immunomodulating enteral nutrition in patients undergoing resection for gastrointestinal cancer. 196 subjects were randomly assigned into two study groups: standard and immunostimulating. The study failed to demonstrate any clear advantage of routine postoperative immunonutrition in patients undergoing elective upper gastrointestinal surgery

Conditions

Interventions

DRUG

Reconvan

isocaloric, immunomodulating entral diet

DRUG

Peptisorb

isocaloric, isopeptic standard diet

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Jan Kulig, MD, PhD · 1st Department of General Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2007-09-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576940 on ClinicalTrials.gov